Investing Profile

Andrew Schiff

VC

Photo of Andrew Schiff, Managing Partner at Aisling Capital
Your Intro Paths to Andrew Schiff

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Andrew Schiff on

cb
Current Investing Position
Aisling Capital Managing Partner
Investments On Record
13
Current Fund Size
$280M

Andrew Schiff's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Forge Biologics
Series CSep 2022$90M
$250M
Co-investors: Chris Garabedian (Perceptive Advisors)
Dren Bio
Series BJun 2022$65M
$130M
Co-investors: Sakae Asanuma (Taiho Ventures)
Monte Rosa Therapeutics
Series BSep 2020$96M
$130M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures)
Zavante Therapeutics
Series AMar 2016$45M
$45M
Co-investors: Patrick Heron (Frazier Healthcare Partners)
Agile Therapeutics
Post-IPO EquityFeb 2015$20M
Series CJul 2012$40M
$110M
Co-investors: Karen Hong (Novo Ventures), Stacey Seltzer (Aisling Capital)
Miramar Labs
Series DOct 2014$26M
$46M
Co-investors: Hank Plain (Morgenthaler Ventures)
Zeltiq Aesthetics
Series DJun 2010$25M
$50M
Co-investors: Bryan Roberts (Venrock)
Asensus Surgical
Post-IPO EquityOct 2009$55M
$55M
Co-investors: Paul LaViolette (SV Health Investors)